On January 19, 2016, Eric Furfine notified Eleven Biotherapeutics, Inc. of his resignation as Chief Scientific Officer of the Company, effective February 5, 2016. Upon the effectiveness of his resignation, the Company expects that Mr. Furfine will join the Company's Scientific Advisory Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | +20.31% |
|
+50.98% | -47.44% |
06-28 | Wall Street Set to Open Higher Friday as Key Inflation Data Indicates Cooling Inflation | MT |
06-28 | Sector Update: Health Care Stocks Higher Pre-Bell Friday | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.44% | 63.14M | |
+15.20% | 121B | |
+19.67% | 113B | |
+17.12% | 26.02B | |
-23.86% | 19.39B | |
-19.61% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Eleven Biotherapeutics, Inc. Announces Resignation of Eric Furfine as Chief Scientific Officer, Effective February 5, 2016